NEW YORK, Nov. 04, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Honeywell International Inc. (NYSE: HON)
Class Period: February 9, 2018 - October 19, 2018
Lead Plaintiff Deadline: December 31, 2018
Join the action: https://www.zlk.com/pslra-1/honeywell-international-inc-loss-form?wire=3
About the lawsuit: Honeywell International Inc. allegedly made materially false and/or misleading statements during the class
period and/or failed to disclose that: (1) Honeywell’s Bendix Friction Materials ("Bendix") asbestos-related liability was greater
than initially reported; (2) the Company maintained improper accounting practices in connection with its Bendix asbestos-related
liability; and (3) as a result, Honeywell’s public statements were materially false and misleading at all relevant times.
Honeywell previously owned Bendix, which used asbestos in its brake- and clutch-pad products until 2001; the Company sold Bendix
in 2014. On August 23, 2018, Honeywell announced it had "revised its method for reasonably estimating its liability for unasserted
Bendix asbestos-related claims by considering the epidemiological projections through 2059 of future incidence of Bendix
asbestos-related disease. Using this method, the Company’s Bendix asbestos-related liability is estimated to be $1,693 million as
of June 30, 2018. This is $1,083 million higher than the Company’s prior estimation which applied a five-year horizon when
estimating the liability for unasserted Bendix asbestos-related claims. The Bendix asbestos-related insurance assets are estimated
to be $187 million as of June 30, 2018, which is $65 million higher than the Company’s prior estimate."
To learn more about the Honeywell International Inc. class action contact jlevi@levikorsinsky.com.
Dycom Industries, Inc. (NYSE: DY)
Class Period: November 20, 2017 - August 10, 2018
Lead Plaintiff Deadline: December 24, 2018
Join the action: https://www.zlk.com/pslra-1/dycom-industries-inc-loss-form?wire=3
About the lawsuit: Dycom Industries, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose
that: (i) Dycom’s large projects were highly dependent on permitting and tactical considerations, (ii) Dycom was facing great
uncertainties related to permitting issues; (iii) said uncertainties would expose Dycom to near-term margin pressure and absorption
issues, and (iv) as a result of the foregoing, Defendants’ statements about Dycom’s business, operations, and prospects, were false
and misleading and/or lacked a reasonable basis.
To learn more about the Dycom Industries, Inc. class action contact jlevi@levikorsinsky.com.
Nektar Therapeutics (NASDAQ: NKTR)
Class Period: November 11, 2017 - October 2, 2018
Lead Plaintiff Deadline: December 31, 2018
Join the action: https://www.zlk.com/pslra-1/nektar-therapeutics-loss-form?wire=3
About the lawsuit: Nektar Therapeutics allegedly made materially false and/or misleading statements during the class period
and/or failed to disclose that: (1) prior studies which attempted to pegylate IL-2 failed; (2) the extended half-life of the
Company's lead I-O candidate, NKTR-214, was unlikely to result in efficacy and created additional high-dosing safety concerns; (3)
NKTR-214 was less effective than IL-2 alone; (4) the combination of NKTR-214 with nivolumab has yet to demonstrate significant
positive results; and (5) as a result, Nektar’s public statements as set forth above were materially false and misleading at all
relevant times.
To learn more about the Nektar Therapeutics class action contact jlevi@levikorsinsky.com.
Fitbit Inc. (NYSE: FIT)
Class Period: August 2, 2016 - January 30, 2017
Lead Plaintiff Deadline: December 31, 2018
Join the action: https://www.zlk.com/pslra-1/fitbit-inc-loss-form?wire=3
About the lawsuit: During the class period, Fitbit Inc. allegedly made materially false and/or misleading statements and/or
failed to disclose that: (1) the company was struggling to transition its mission and differentiate itself from Apple Inc. and
other competitors; (2) as such, the Company was experiencing increased competition; (3) as a result, demand and sell-through for
the Company’s existing and new products were being negatively impacted; (4) as a result, the Company’s sales and financial results
were weakening, and growth was slowing; (5) the Company’s financial guidance was overstated; and (6) as a result of the foregoing,
Defendants’ statements during the Class Period about Fitbit’s business, operations, financial results and prospects, were
materially false and/or misleading and/or lacked a reasonable basis.
To learn more about the Fitbit Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
